A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-α gene-deficient mice

Inflammatory Bowel Diseases

Volumn 12, Issue 8, 2006, Pages 750-757

  Sydora, Beate C ^a   Tavernini, Michele M ^a   Doyle, Jason ^b   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Vernon Jubilee Hospital   (Canada)

Author keywords

Crohn's disease; Epithelial barrier; Inflammatory bowel disease; Permeability; TCR gene deficient mice; Ulcerative colitis

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MANNITOL; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENTERITIS; ENTEROCOLITIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; INJURY SEVERITY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; ORGAN CULTURE; PERFUSION; PRIORITY JOURNAL; RECEPTOR GENE; SPLEEN CELL; TECHNIQUE; WILD TYPE;

AGE FACTORS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIA; COLITIS; DISEASE MODELS, ANIMAL; EPITHELIUM; GENES, T-CELL RECEPTOR ALPHA; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTESTINAL MUCOSA; MANNITOL; MICE; MICE, KNOCKOUT; PERMEABILITY; SPLEEN; T-LYMPHOCYTES;

EID: 33747445882     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/00054725-200608000-00012     Document Type: Article

References (38)

1. Madsen KL, Malfair D, Gray D, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262-270.
2. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 1995;270:1203-1207.
3. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 1998;161:5733-5744.
4. Schmitz H, Barmeyer C, Gitter AH, et al. Epithelial barrier and transport function of the colon in ulcerative colitis. Ann N Y Acad Sci. 2000;915:312-326.
5. Gitter AH, Wullstein F, Fromm M, et al. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001;121:1320-1328.
6. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385-396.
7. Hollander D. Permeability in Crohn's disease: altered barrier functions in healthy relatives? Gastroenterology. 1993;104:1848-1851.
8. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology. 1993;104:1627-1632.
9. Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology. 1997;113:802-807.
10. Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut. 1999;44:96-100.
11. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation. Gut. 2006;55:342-347.
12. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology. 2000;119:1740-1744.
13. Mombaerts P, Mizoguchi E, Grusby MJ, et al. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 1993;75:274-282.
14. Westergaard H, Holtermuller KH, Dietschy JM. Measurement of resistance of barriers to solute transport in vivo in rat jejunum. Am J Physiol. 1986;250:G727-735.
15. Sadowski DC, Meddings JB. Luminal nutrients alter tight-junction permeability in the rat jejunum: an in vivo perfusion model. Can J Physiol Pharmacol. 1993;71:835-839.
16. Saverymuttu SH, CamilleriM, Rees H, et al. Indium-III granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium-III-granulocyte excretion. Gastroenterology. 1986;90:1121-1128.
17. Sydora BC, Tavernini MM, Wessler A, et al. Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs. Inflamm Bowel Dis. 2003;9:87-97.
18. Bhan AK, Mizoguchi E, Smith RN, et al. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev. 1999;169:195-207.
19. Duchmann R, Marker-Hermann E, Meyer zum Buschenfelde KH. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol. 1996;44:71-79.
20. Duchmann R, May E, Heike M, et al. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut. 1999;44:812-818.
21. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689-699.
22. Sydora BC, Tavernini MM, Doyle JS, et al. Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response. Dig Dis Sci. 2005;50:905-913.
23. + T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology. 1997;112:1876-1886.
24. Smith KM, Davidson JM, Garside P. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology. 2002;106:144-158.
25. Gutgemann I, Fahrer AM, Altman JD, et al. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity. 1998;8:667-673.
26. Hollander GA, Simpson SJ, Mizoguchi E, et al. Severe colitis in mice with aberrant thymic selection. Immunity. 1995;3:27-38.
27. Ludviksson BR, Gray B, Strober W, et al. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J Immunol. 1997;158:104-111.
28. Clegg CH, Rulffes JT, Haugen HS, et al. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int Immunol. 1997;9:1111-1122.
29. Brown SJ, Miller AM, Cowan PJ, et al. Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice. Inflamm Bowel Dis. 2004;10:546-556.
30. Mizoguchi A, Mizoguchi E, Chiba C, et al. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med. 1996;183:847-856.
31. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2:361-367.
32. Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med. 2000;191:1381-1394.
33. Mombaerts P, Clarke AR, Rudnicki MA, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature. 1992;360:225-231.
34. Mombaerts P, Mizoguchi E, Ljunggren HG, et al. Peripheral lymphoid development and function in TCR mutant mice. Int Immunol. 1994;6:1061-1070.
35. Matsuda JL, Gapin L, Sydora BC, et al. Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. J Immunol. 2000;164:2797-2806.
36. Mizoguchi A, Mizoguchi E, Chiba C, et al. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med. 1996;184:707-715.
37. Mizoguchi A, Mizoguchi E, Tonegawa S, et al. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR alpha mutant mice with inflammatory bowel disease. Int Immunol. 1996;8:1387-1394.
38. Takahashi I, Iijima H, Katashima R, et al. Clonal expansion of CD4+ TCRbetabeta+ T cells in TCR alpha-chain-deficient mice by gut-derived antigens. J Immunol. 1999;162:1843-1850.